Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence
Titel:
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence
Auteur:
Caponnetto, S. Gelibter, A. Mosillo, C. Magri, V. Scagnoli, S. Pomati, G. Piesco, G. Verkhovskaya, S. Pisegna, S. Sirgiovanni, G. Napoli, V. Buscicchio, D. Iannantuono, G.M. Marinelli, D. Mammone, G. Pannunzio, S. Nicolo', E. Stefani, A. Astorino, V. Mancini, M. Cortesi, E.